These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
136 related items for PubMed ID: 3904322
21. Drugs in pregnancy. Antihypertensives. Magee LA. Best Pract Res Clin Obstet Gynaecol; 2001 Dec; 15(6):827-45. PubMed ID: 11800527 [Abstract] [Full Text] [Related]
22. A placebo controlled trial of metoprolol in the treatment of hypertension in pregnancy. Wichman K, Rydén G, Karlberg BE. Scand J Clin Lab Invest Suppl; 1984 Dec; 169():90-5. PubMed ID: 6387888 [No Abstract] [Full Text] [Related]
23. Treatment with propranolol and hydralazine throughout pregnancy in a hypertensive patient. A case report. Bott-Kanner G, Schweitzer A, Schoenfeld A, Joel-Cohen J, Rosenfeld JB. Isr J Med Sci; 1978 Apr; 14(4):466-8. PubMed ID: 669924 [Abstract] [Full Text] [Related]
24. Transplacental passage and breast milk concentrations of hydralazine. Liedholm H, Wåhlin-Boll E, Hanson A, Ingemarsson I, Melander A. Eur J Clin Pharmacol; 1982 Apr; 21(5):417-9. PubMed ID: 7200428 [Abstract] [Full Text] [Related]
25. Factor analysis, including antihypertensive medication, of the outcome of pregnancy in pregnancy-associated hypertension. Hussein M, Mooij JM, Roujouleh H. Kidney Blood Press Res; 2001 Apr; 24(2):124-8. PubMed ID: 11435745 [Abstract] [Full Text] [Related]
26. Effects of beta 1-adrenoceptor blockade in the treatment of hypertension during pregnancy in diabetic women. Olofsson P, Montan S, Sartor G, Sjöberg NO. Acta Med Scand; 1986 Apr; 220(4):321-8. PubMed ID: 3541500 [Abstract] [Full Text] [Related]
30. Changes in fetal and maternal Doppler parameters observed during acute severe hypertension treatment with hydralazine or labetalol: a randomized controlled trial. Baggio MR, Martins WP, Calderon AC, Berezowski AT, Marcolin AC, Duarte G, Cavalli RC. Ultrasound Med Biol; 2011 Jan; 37(1):53-8. PubMed ID: 21084154 [Abstract] [Full Text] [Related]
31. Hypertension in pregnancy. Pathophysiology and management. Lubbe WF. Drugs; 1984 Aug; 28(2):170-88. PubMed ID: 6147240 [Abstract] [Full Text] [Related]
32. Maternal and fetal haemodynamics in hypertensive pregnancies during maternal treatment with intravenous hydralazine or labetalol. Harper A, Murnaghan GA. Br J Obstet Gynaecol; 1991 May; 98(5):453-9. PubMed ID: 2059591 [Abstract] [Full Text] [Related]
33. Hydralazine vs nifedipine for acute hypertensive emergency in pregnancy: a randomized controlled trial. Sharma C, Soni A, Gupta A, Verma A, Verma S. Am J Obstet Gynecol; 2017 Dec; 217(6):687.e1-687.e6. PubMed ID: 28867601 [Abstract] [Full Text] [Related]
34. Comparison of outcome of labetalol or hydralazine therapy during hypertension in pregnancy in very low birth weight infants. Hjertberg R, Faxelius G, Belfrage P. Acta Obstet Gynecol Scand; 1993 Nov; 72(8):611-5. PubMed ID: 8259746 [Abstract] [Full Text] [Related]
35. The safety of antihypertensives for treatment of pregnancy hypertension. Magee LA, Abdullah S. Expert Opin Drug Saf; 2004 Jan; 3(1):25-38. PubMed ID: 14680459 [Abstract] [Full Text] [Related]
38. Comparison of antihypertensive efficacy and perinatal safety of labetalol and methyldopa in the treatment of hypertension in pregnancy: a randomized controlled trial. Plouin PF, Breart G, Maillard F, Papiernik E, Relier JP. Br J Obstet Gynaecol; 1988 Sep; 95(9):868-76. PubMed ID: 3056503 [Abstract] [Full Text] [Related]